Home › Funds › Impax Global Social Leaders Fund
Fund family: IMPAX FUNDS SERIES TRUST I · Filed by IMPAX FUNDS SERIES TRUST I (CIK 76721) · SEC series S000083017
Share classes and tickers: IGSIX (C000246502), IGSLX (C000246501)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 228 with, 15 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 5 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.
Each ballot item this fund voted is set against the votes of the other IMPAX FUNDS SERIES TRUST I funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most IMPAX FUNDS SERIES TRUST I funds on all 8 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 117 | 2 |
| Corporate Governance | 38 | 3 |
| Compensation | 33 | 2 |
| Capital Structure | 24 | 0 |
| Audit-related | 15 | 4 |
| Say-on-Pay | 7 | 2 |
| Shareholder Rights and Defenses | 5 | 1 |
| Other Social Issues | 3 | 0 |
| Diversity, Equity, and Inclusion | 1 | 1 |
| Extraordinary Transactions | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Agilent Technologies, Inc. | March 18, 2026 | $81,469 | 7 | 2 |
| Pinnacle Financial Partners, Inc. | November 6, 2025 | $62,850 | 3 | 1 |
| Palo Alto Networks, Inc. | December 9, 2025 | $59,425 | 8 | 3 |
| Gilead Sciences, Inc. | April 30, 2026 | $51,279 | 15 | 2 |
| Intuitive Surgical, Inc. | April 30, 2026 | $44,650 | 13 | 0 |
| Intuit Inc. | January 22, 2026 | $34,902 | 14 | 2 |
| Boston Scientific Corporation | April 30, 2026 | $26,832 | 17 | 3 |
| ServiceNow, Inc. | December 5, 2025 | $7,951 | 1 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 18, 2026 | Agilent Technologies, Inc. | Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: George A. Scangos, Ph.D. | For | Against |
| March 18, 2026 | Agilent Technologies, Inc. | To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. | For | Against |
| November 6, 2025 | Pinnacle Financial Partners, Inc. | A proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Pinnacle's named executive officers in connection with the transactions contemplated by the merger agreement. | For | Against |
| December 9, 2025 | Palo Alto Networks, Inc. | Election of Class II Directors: John M. Donovan | For | Against |
| December 9, 2025 | Palo Alto Networks, Inc. | To approve, on an advisory basis, the compensation of our named executive officers. | For | Against |
| April 30, 2026 | Gilead Sciences, Inc. | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | For | Against |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| January 22, 2026 | Intuit Inc. | Ratification of the selection of Ernst & Young LLP as Intuit's independent registered public accounting firm for the fiscal year ending July 31, 2026 | For | Against |
| January 22, 2026 | Intuit Inc. | Shareholder proposal requesting the Board issue a report on the return on investment of the Company's diversity and inclusion programs Shareholder proposal | Against | For |
| April 30, 2026 | Boston Scientific Corporation | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. | For | Against |
| April 30, 2026 | Boston Scientific Corporation | To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. | For | Against |
| June 24, 2026 | Recruit Holdings Co., Ltd. | Elect Takashi Nishimura as Statutory Auditor | For | Against |
244 ballot items at 18 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Impax Global Social Leaders Fund (IGSIX) voted at 18 shareholder meetings of 18 companies, on 244 ballot items in all. Where management made a recommendation, the fund followed it on 93.8% of the items and voted against it 15 times. Its most frequent area of disagreement was audit-related (4 of its votes against management). It voted on 12 shareholder proposals. It voted the same way as most IMPAX FUNDS SERIES TRUST I funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.